Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert B. Pelletier | M | 71 | - | |
| Samuel K. Ackerman | M | - | 1 years | |
| Peyton J. Marshall | M | 69 | 2 years | |
| Joseph Slattery | M | 59 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 5 years |
| Laurent Fischer | M | 60 | - | |
| Frederick Schmid | M | 67 | 2 years | |
| John Richards | M | 67 | 3 years | |
| Phillip Schneider | M | 68 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 1 years |
| Christopher P. Schnittker | M | 55 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 1 years |
| Eric Linsley | M | 62 | 2 years | |
| R. Fletcher | M | 78 | 4 years | |
| David E. Martin | M | 57 | - | |
| Mark Reisenauer | M | 58 |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 13 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Donald A. Zelm
- Personal Network
